» Articles » PMID: 24120137

Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling

Abstract

Hepatocellular carcinoma (HCC) is a slowly developing malignancy postulated to evolve from premalignant lesions in chronically damaged livers. However, it was never established that premalignant lesions actually contain tumor progenitors that give rise to cancer. Here, we describe isolation and characterization of HCC progenitor cells (HcPCs) from different mouse HCC models. Unlike fully malignant HCC, HcPCs give rise to cancer only when introduced into a liver undergoing chronic damage and compensatory proliferation. Although HcPCs exhibit a similar transcriptomic profile to bipotential hepatobiliary progenitors, the latter do not give rise to tumors. Cells resembling HcPCs reside within dysplastic lesions that appear several months before HCC nodules. Unlike early hepatocarcinogenesis, which depends on paracrine IL-6 production by inflammatory cells, due to upregulation of LIN28 expression, HcPCs had acquired autocrine IL-6 signaling that stimulates their in vivo growth and malignant progression. This may be a general mechanism that drives other IL-6-producing malignancies.

Citing Articles

NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance.

Shi S, Ou X, Liu C, Li R, Zheng Q, Hu L Front Immunol. 2025; 16:1518664.

PMID: 39949765 PMC: 11821961. DOI: 10.3389/fimmu.2025.1518664.


Arsenite exposure induces premature senescence and senescence-associated secretory phenotype (SASP) in human hepatocyte-derived cell line Huh-7.

Okamura K, Sato M, Suzuki T, Nohara K Environ Health Prev Med. 2025; 29:74.

PMID: 39756915 PMC: 11701098. DOI: 10.1265/ehpm.24-00139.


FBP1 controls liver cancer evolution from senescent MASH hepatocytes.

Gu L, Zhu Y, Nandi S, Lee M, Watari K, Bareng B Nature. 2025; 637(8045):461-469.

PMID: 39743585 DOI: 10.1038/s41586-024-08317-9.


Paradoxical link between senescent cell state and liver cancer resolved.

Nature. 2025; .

PMID: 39743551 DOI: 10.1038/d41586-024-04137-z.


Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance.

Gawi Ermi A, Sarkar D Cancers (Basel). 2024; 16(23).

PMID: 39682130 PMC: 11640171. DOI: 10.3390/cancers16233944.


References
1.
Inokuchi S, Aoyama T, Miura K, Osterreicher C, Kodama Y, Miyai K . Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci U S A. 2010; 107(2):844-9. PMC: 2818947. DOI: 10.1073/pnas.0909781107. View

2.
Marquardt J, Thorgeirsson S . Stem cells in hepatocarcinogenesis: evidence from genomic data. Semin Liver Dis. 2010; 30(1):26-34. PMC: 3492884. DOI: 10.1055/s-0030-1247130. View

3.
Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C . Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature. 1995; 376(6543):768-71. DOI: 10.1038/376768a0. View

4.
Rabes H . Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens. J Cancer Res Clin Oncol. 1983; 106(2):85-92. DOI: 10.1007/BF00395384. View

5.
Park E, Lee J, Yu G, He G, Ali S, Holzer R . Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010; 140(2):197-208. PMC: 2836922. DOI: 10.1016/j.cell.2009.12.052. View